Immatics N.V (IMTX) | Financial Analysis & Statements
Immatics N.V. Small-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
19.8M
Operating Income
-38.9M
-196.76%
Net Income
-35.7M
-180.65%
Balance Sheet Metrics
Total Assets
562.3M
Total Liabilities
78.2M
Shareholders Equity
484.1M
Debt to Equity
0.16
Cash Flow Metrics
Operating Cash Flow
-60.5M
Free Cash Flow
-59.7M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Immatics N.V Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 48.3M | 155.8M | 54.0M | 172.8M | 34.8M |
| Cost of Goods Sold | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
| Gross Margin % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Expenses | |||||
| Research & Development | 183.8M | 148.1M | 118.7M | 106.8M | 87.6M |
| Selling, General & Administrative | 51.2M | 46.4M | 38.2M | 36.1M | 33.8M |
| Other Operating Expenses | -4.7M | -78.0K | -1.1M | -26.0K | -325.0K |
| Total Operating Expenses | 230.3M | 194.4M | 155.7M | 142.9M | 121.1M |
| Operating Income | -182.0M | -38.6M | -101.7M | 30.0M | -86.3M |
| Operating Margin % | -377.1% | -24.8% | -188.4% | 17.3% | -248.2% |
| Non-Operating Items | |||||
| Interest Income | 17.2M | 25.0M | 13.8M | 2.5M | 133.0K |
| Interest Expense | 946.0K | 886.0K | 831.0K | 1.0M | 566.0K |
| Other Non-Operating Income | -32.7M | 35.8M | -8.3M | 10.6M | -6.6M |
| Pre-tax Income | -198.4M | 21.3M | -97.0M | 42.0M | -93.3M |
| Income Tax | -2.0M | 6.1M | 0 | 4.5M | 0 |
| Effective Tax Rate % | 0.0% | 28.7% | 0.0% | 10.8% | 0.0% |
| Net Income | -196.4M | 15.2M | -97.0M | 37.5M | -93.3M |
| Net Margin % | -407.0% | 9.8% | -179.6% | 21.7% | -268.5% |
| Key Metrics | |||||
| EBITDA | -152.4M | -1.4M | -80.6M | 39.4M | -80.9M |
| EPS (Basic) | - | $0.14 | $-1.20 | $0.56 | $-1.48 |
| EPS (Diluted) | - | $0.14 | $-1.20 | $0.55 | $-1.48 |
| Basic Shares Outstanding | - | 105744929 | 74635763 | 65340009 | 61364004 |
| Diluted Shares Outstanding | - | 105744929 | 74635763 | 65340009 | 61364004 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Immatics N.V Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 345.9M | 236.7M | 218.5M | 148.5M | 133.0M |
| Short-term Investments | 123.4M | 367.7M | 207.4M | 213.7M | 12.1M |
| Accounts Receivable | 6.1M | 5.9M | 4.1M | 1.1M | 682.0K |
| Inventory | - | - | - | - | - |
| Other Current Assets | 14.9M | 6.3M | 7.1M | 2.4M | 950.0K |
| Total Current Assets | 504.0M | 629.6M | 449.4M | 377.2M | 152.2M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 34.4M | 38.5M | 39.5M | 23.1M | 20.3M |
| Goodwill | 1.6M | 1.6M | 1.5M | 1.6M | 1.3M |
| Intangible Assets | 1.6M | 1.6M | 1.5M | 1.6M | 1.3M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 769.0K | 917.0K | 603.0K | 639.0K | - |
| Total Non-Current Assets | 58.3M | 66.6M | 60.6M | 30.7M | 22.4M |
| Total Assets | 562.3M | 696.1M | 510.0M | 407.8M | 174.6M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 340.0K | 10.1M | 7.7M | 4.0M | 3.0M |
| Short-term Debt | 2.8M | 2.9M | 2.6M | 2.2M | 2.7M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 1.6M | 3.2M | 19.2M | 17.1M | 28.0M |
| Total Current Liabilities | 43.0M | 68.0M | 156.6M | 106.5M | 95.1M |
| Non-Current Liabilities | |||||
| Long-term Debt | 12.9M | 13.4M | 12.8M | 12.4M | 7.1M |
| Deferred Tax Liabilities | 3.8M | 5.8M | - | - | - |
| Other Non-Current Liabilities | - | - | 4.0K | 42.0K | 68.0K |
| Total Non-Current Liabilities | 35.2M | 53.3M | 128.3M | 88.2M | 55.4M |
| Total Liabilities | 78.2M | 121.3M | 284.9M | 194.7M | 150.6M |
| Equity | |||||
| Common Stock | 1.3M | 1.2M | 847.0K | 767.0K | 629.0K |
| Retained Earnings | -786.0M | -589.5M | -597.3M | -500.3M | -537.8M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 484.1M | 574.8M | 225.1M | 213.2M | 24.1M |
| Key Metrics | |||||
| Total Debt | 15.6M | 16.2M | 15.4M | 14.6M | 9.9M |
| Working Capital | 461.0M | 561.6M | 292.8M | 270.7M | 57.1M |
Balance Sheet Composition
Immatics N.V Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -196.4M | 15.2M | -97.0M | 42.0M | -93.3M |
| Depreciation & Amortization | 12.4M | 12.2M | 7.2M | 7.0M | 5.3M |
| Stock-Based Compensation | 15.0M | 17.6M | 20.7M | 22.6M | 26.4M |
| Working Capital Changes | -44.0M | -163.9M | 81.6M | 37.3M | -63.5M |
| Operating Cash Flow | -231.2M | -136.8M | -439.0K | 111.9M | -124.7M |
| Investing Activities | |||||
| Capital Expenditures | -6.6M | -16.3M | -30.6M | -5.7M | -5.1M |
| Acquisitions | - | - | - | - | - |
| Investment Purchases | -338.3M | -450.3M | -415.3M | -216.3M | -11.3M |
| Investment Sales | 549.9M | 314.4M | 414.7M | 12.7M | 24.4M |
| Investing Cash Flow | 205.0M | -152.2M | -31.2M | -209.3M | 8.0M |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | - | - | - | - | - |
| Debt Repayment | -3.0M | -2.0M | -3.8M | -2.8M | -2.7M |
| Financing Cash Flow | 97.4M | 319.7M | 84.5M | 123.7M | -2.6M |
| Free Cash Flow | -183.4M | -174.5M | -12.7M | 93.9M | -90.4M |
| Net Change in Cash | 71.2M | 30.7M | 52.8M | 26.3M | -119.3M |
Cash Flow Trend
Immatics N.V Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
26.82
Forward P/E
-6.31
Price to Book
2.62
Price to Sales
31.06
PEG Ratio
-6.31
Profitability Ratios
Profit Margin
0.00%
Operating Margin
-196.76%
Return on Equity
-37.10%
Return on Assets
-18.08%
Financial Health
Current Ratio
11.72
Debt to Equity
3.23
Beta
1.34
Per Share Data
EPS (TTM)
$-1.89
Book Value per Share
$4.26
Revenue per Share
$0.39
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| IMTX | 1.5B | 26.82 | 2.62 | -37.10% | 0.00% | 3.23 |
| Vertex | 109.4B | 28.40 | 5.92 | 22.54% | 32.94% | 10.91 |
| Regeneron | 81.0B | 18.00 | 2.45 | 14.86% | 31.41% | 9.51 |
| Recursion | 1.9B | -2.44 | 1.64 | -59.54% | 4.45% | 6.89 |
| Capricor | 2.0B | -15.61 | 6.62 | -46.56% | 0.00% | 4.75 |
| Zymeworks | 2.0B | 3.79 | 7.32 | -26.72% | -76.56% | 6.80 |
Financial data is updated regularly. All figures are in the company's reporting currency.






